For two decades, the federal government has encouraged transparency in research. As a result of these efforts, it established ClinicalTrials.gov, a national registry of U.S....
Read The ArticleRead about the approach to drug development that includes tolerability, ease of use, compliance with therapy, and quality of life as topics addressed along with...
Read The ArticleView OHRP’s 2020 edition of the International Compilation of Human Research Standards. This compilation of laws, regulations, and guidelines is helpful to CITI Program organizations...
Read The ArticleThe NIH Office of Extramural Research (OER) provides a decision tool to help determine if research is considered human subjects research and if it may...
Read The ArticleThe U.S. Departments of Health and Human Services and Education have released “Joint Guidance on the Application of the Family Educational Rights and Privacy Act...
Read The ArticleOn January 20, 2020, the sIRB requirement under the revised Common Rule went into effect. This marked the final step in the timeline for full...
Read The ArticleAfter considering feedback from our subscribing organizations, we have compiled 9 strategies that will help you streamline your account and encourage learners to complete their...
Read The ArticleAlthough single IRB (sIRB) review has long existed as an option for institutions to use for the oversight of human subjects research, most institutions only...
Read The ArticleStanford Medicine has published the complete results of their study, “Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation.” The study utilized user-owned Apple smartwatches...
Read The ArticleCITI Program would like to congratulate PRIM&R’s 2019 ARENA Legacy Award recipient, Susan Z. Kornetsky, MPH, Senior Director of Clinical Research Compliance at Boston Children’s...
Read The Article
